Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Akebia Therapeutics, Inc. (AKBA)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   8-K10-Q8-K10-Q10-Q10-K10-Q10-Q
Net income  -11.2-26.2-7.629.3-62.4-70.7-59.5-83.0
Depreciation and amortization   [+] 9.4 9.49.49.59.59.5
Asset impairment charges   0.3 2.15.38.51.70.4
Stock-based compensation   2.5 6.94.54.65.66.5
Change in working capital   [+] 1.5 -50.3-16.6-34.9-26.0-22.8
Other operating activities   -5.0 -28.038.120.212.526.3
Cash from operations   -17.5 -30.7-21.6-62.8-56.3-63.1
   
Capital expenditures   0.0 0.0-0.10.00.00.0
Sales of short-term investments         20.0
Cash from investing   0.0 0.0-0.10.00.020.0
   
Issuance of common stock, net     -0.17.25.416.137.4
Option exercises   0.0 0.10.4 0.4 
Other cash from financing   -15.9 0.140.7 0.8 
Cash from financing   -16.0 0.047.55.416.537.4
   
Free cash flow   -17.5 -30.7-21.7-62.8-56.3-63.1
        Per share (diluted)   ($0.09) ($0.16)($0.12)($0.38)($0.32)($0.39)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy